Suppr超能文献

种族差异与糖尿病性心肌病:ARISE-HF 试验。

Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.

机构信息

Division of Cardiovascular Disease, University of Miami Miller School of Medicine, JFK Hospital, Lantana, Florida, USA.

Division of Cardiology, Massachusetts General Hospital, Baim Institute for Clinical Research, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Am Coll Cardiol. 2024 Jul 16;84(3):233-243. doi: 10.1016/j.jacc.2024.04.053.

Abstract

BACKGROUND

Diabetic cardiomyopathy (DbCM) increases risk of overt heart failure in individuals with diabetes mellitus. Racial and ethnic differences in DbCM remain unexplored.

OBJECTIVES

The authors sought to identify racial and ethnic differences among individuals with type 2 diabetes mellitus, structural heart disease, and impaired exercise capacity.

METHODS

The ARISE-HF (Aldolase Reductase Inhibitor for Stabilization of Exercise Capacity in Heart Failure) trial is assessing the efficacy of an aldose reductase inhibitor for exercise capacity preservation in 691 persons with DbCM. Baseline characteristics, echocardiographic parameters, and functional capacity were analyzed and stratified by race and ethnicity.

RESULTS

The mean age of the study participants was 67.4 years; 50% were women. Black and Hispanic patients had lower use of diabetes mellitus treatments. Black patients had poorer baseline ventricular function and more impaired global longitudinal strain. Overall, health status was preserved, based on Kansas City Cardiomyopathy Questionnaire scores, but reduced exercise capacity was present as evidenced by reduced Physical Activity Scale for the Elderly (PASE) scores. When stratified by race and ethnicity and compared with the entire cohort, Black patients had poorer health status, more reduced physical activity, and a greater impairment in exercise capacity during cardiopulmonary exercise testing, whereas Hispanic patients also displayed compromised cardiopulmonary exercise testing functional capacity. White patients demonstrated higher physical activity and functional capacity.

CONCLUSIONS

Racial and ethnic differences exist in baseline characteristics of persons affected by DbCM, with Black and Hispanic study participants demonstrating higher risk features. These insights inform the need to address differences in the population with DbCM. (Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy [ARISE-HF]; NCT04083339).

摘要

背景

糖尿病性心肌病(DbCM)会增加糖尿病患者发生显性心力衰竭的风险。但目前仍不清楚 DbCM 患者在种族和民族方面存在的差异。

目的

作者旨在确定 2 型糖尿病、结构性心脏病和运动能力受损的个体之间存在的种族和民族差异。

方法

ARISE-HF(醛糖还原酶抑制剂稳定心力衰竭患者运动能力)试验评估了醛糖还原酶抑制剂对 691 例 DbCM 患者运动能力的保护作用。对基线特征、超声心动图参数和功能能力进行了分析,并按种族和民族进行了分层。

结果

研究参与者的平均年龄为 67.4 岁,其中 50%为女性。黑人和西班牙裔患者的糖尿病治疗使用率较低。黑种人患者的基础心室功能更差,整体纵向应变更受损。基于堪萨斯城心肌病问卷评分,整体健康状况得以维持,但由于体力活动量表评分降低,运动能力下降。按种族和民族分层并与整个队列进行比较时,黑种人患者的健康状况更差,体力活动减少,心肺运动试验时运动能力受损更严重,而西班牙裔患者的心肺运动试验功能能力也受损。白种人患者的体力活动和功能能力更高。

结论

DbCM 患者的基线特征存在种族和民族差异,黑人和西班牙裔研究参与者具有更高的风险特征。这些发现为解决 DbCM 人群的差异提供了信息。(糖尿病性心肌病患者 AT-001 的安全性和有效性[ARISE-HF];NCT04083339)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验